Shanghai Henlius Biotech, Inc. (2696.HK) HKSE
69.00
-3(-4.17%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
69.00
-3(-4.17%)
Currency In HKD
| Market Cap | 27.85B |
| Enterprise Value | 30.68B |
| P/E Ratio | 53.53 |
| PEG Ratio | 2.85 |
| Price/Sales Ratio | 7.54 |
| Price/Book Ratio | 8.21 |
| Enterprise/Revenue | 8.2 |
| Enterprise/EBITDA | 41.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.14 |
| Operating Margin | 0.15 |
| Return On Assets | 0.05 |
| Return On Equity | 0.18 |
| Revenue | 6.49B |
| Revenue/Share | 7.93 |
| Gross Profit | 4.81B |
| EBITDA | 1.21B |
| Net Income | 805.64M |
| Diluted EPS | 1.47 |
| Total Cash | 772.21M |
| Total Cash/Share | 1.42 |
| Total Debt | 3.6B |
| Total Debt/Equity | 0.91 |
| Current Ratio | 0.71 |
| Book Value Per Share | 7.29 |
| 52-Week Change | 88.52 |
| 52-Week High | 92 |
| 52-Week Low | 36.5 |
| Moving Average 50 Days | 73.75 |
| Moving Average 200 Days | 70.49 |
| Average Volume | 931,768 |
| Shares Outstanding | 543.49M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |